For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...

New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and patients crucial ...

Patients with stage II and IIIB non-small cell lung cancer (NSCLC) with an EGFR mutation had better outcomes when treated ...

Survival outcomes favored the higher dose: more than 93% of patients in the 70 Gy group were alive one year after treatment, ...

Tracking the trajectory of symptoms may be an improvement over the traditional way of collecting patient-reported outcomes ...

Dr. Jared Weiss details the importance of continued research into novel therapies for patients with lung cancer.

The MHRA has approved aumolertinib for adult patients with non-small cell lung cancer (NSCLC), following a groundbreaking ...

Dr. Bryant Lin, who has stage 4 lung cancer, created a Stanford class that follows his journey, offering students an ...

Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, ...